Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention: a GRADE-assessed meta-analysis with trial sequential analysis
Authors
Basant E. Katamesh (ORCID: https://orcid.org/0000-0001-9992-2387)
Pierre François Sabouret (ORCID: https://orcid.org/0000-0002-0243-3673)
Naiela E Almansouri (ORCID: https://orcid.org/0009-0002-8103-751X)
Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention: a GRADE-assessed meta-analysis with trial sequential analysis
Basant E. Katamesh, Pierre François Sabouret, Naiela E Almansouri, Hossam Elbenawi et al.
Journal
Journal of Cardiovascular Medicine
Topics
Antiplatelet Therapy and Cardiovascular Diseases
article
Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention: a GRADE-assessed meta-analysis with trial sequential analysis
Basant E. Katamesh, Pierre François Sabouret, Naiela E Almansouri, Hossam Elbenawi, Amer Af, Ahmed Ibrahim, Giuseppe Andò, Imad SammanTahhan
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Cardiovascular MedicineVol. 27(2)
Institutions
Mayo Clinic (US), Wellington City Council (NZ), Sorbonne Université (FR), Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT), Mayo Clinic in Florida (US), Alexandria University (EG)